US measles cases surpass 2,000 for the 2nd year in a row: CDC
Human crowd surrounding an injectable measles vaccine bottle on purple background. Horizontal composition with copy space. ( MicroStockHub/Getty Images)
(NEW YORK) — Measles cases in the United States have surpassed 2,000 for the second year in a row, according to data updated Friday from the Centers for Disease Control and Prevention (CDC).
So far in 2026, 2,030 confirmed cases have been recorded in 39 states and the District of Columbia, CDC data shows.
Cases have been confirmed in: Alaska, Arizona, California, Colorado, Florida, Georgia, Idaho, Illinois, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Missouri, Montana, Nebraska, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Texas, Utah, Vermont, Virginia, Washington, Wisconsin and Wyoming.
Just 10 measles cases were reported among international travelers so far this year, according to CDC data.
Last year, 2,288 confirmed measles cases were reported for all of 2025. Prior to this, measles cases had not surpassed 2,000 in the U.S. since 1992.
The majority of measles cases have been confirmed among children and teenagers aged 19 and younger, according to the CDC.
About 92% of cases are among people who are unvaccinated or whose vaccination status is unknown, CDC data shows.
Meanwhile, 4% of cases are among those who have received just one dose of the measles, mumps, rubella (MMR) vaccine and 4% of cases are among those who received the recommended two doses, according to the CDC.
This is a developing story. Please check back for updates.
Bottles of children’s ibuprofen, made for Taro Pharmaceuticals U.S.A., Inc., are being recalled due to the potential presence of a foreign substance. (NIH)
(NEW YORK) — Nearly 90,000 bottles of children’s ibuprofen are being voluntarily recalled due to the potential presence of a foreign substance.
According to a notice from the Food and Drug Administration, Taro Pharmaceuticals U.S.A., Inc. received complaints from customers who reported “a gel-like mass and black particles” in the drug products.
Four-ounce (120 ml) bottles of Children’s Ibuprofen Oral Suspension are impacted by the recall. The FDA said the children’s medications, intended for pain relief from the common cold, flu, sore throat, headache and toothache and a fever reducer, were manufactured in India for Taro Pharmaceuticals U.S.A., Inc.
Recalled children’s ibuprofen products have lot codes of: 7261973A and 7261974A and bear an expiration date of 01/31/2027, according to the federal agency.
The FDA is classifying the recall as a Class II, which the agency defines as anything where the “use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.”
ABC News has reached out to Taro Pharmaceuticals and its parent company Sun Pharma for comment.
Stock photo of people commuting on e-bikes and scooters. (Maskot/STOCK PHOTO/Getty Images)
(NEW YORK) — E-bikes and e-scooters led to a growing number of trauma injuries at one New York City hospital, according to a new study published Wednesday.
About 7% of all trauma visits between 2018 and 2023 at Bellevue Hospital Center were due to micromobility injuries. Micromobility is the use of small, lightweight and low-speed modes of transportation such as bicycles, e-bikes and e-scooters.
The study showed a growing share of patients who sustained these injuries had accidents linked to e-bikes or e-scooters.
Hospital data showed that, by 2023, over half of all trauma cases related to bikes or scooters involved an e-bike or e-scooter, an increase from just 8% in 2018, according to the study, published in the journal Neurosurgery.
The most common type of mechanism involved a collision with a motor vehicle followed by falls from the bike or scooter.
Bellevue is a Level 1 Trauma center in a large metropolitan city, designed to treat the worst kinds of injuries. Over the study period, about 30% of patients suffered a traumatic brain injury, 26% had injury to the skull or face and 50% required surgery.
“Our study shows that micromobility injuries are producing serious brain and spinal trauma that demands neurosurgical care at a scale we haven’t seen before,” corresponding study author Dr. Hannah Weiss, a resident in the Department of Neurosurgery at NYU Grossman School of Medicine, said in a press release. “In a busy urban setting, we are seeing more and more of these injuries firsthand.”
Most patients seen for these injuries, nearly 69%, needed to be admitted to the hospital and nearly a third needed intensive care.
The majority of patients stayed at least three days in the hospital. Pedestrians who were struck had higher rates of traumatic brain injuries and were more likely to be admitted for intensive care.
“The data point to actionable solutions — helmet use, safer bike lane design and enforcement — that could prevent many of these injuries and better protect both riders and pedestrians, who in our study often sustained even more severe brain injuries than the riders themselves,” Weiss said.
About 20% of patients were intoxicated with alcohol, only 31% were using a helmet and injuries were more likely to occur in the evening hours, according to the study.
“Our findings make clear that urban infrastructure must continue to improve to keep pace with the rapid rise of electric bikes and scooters,” Dr. Paul P. Huang, an associate professor in the department of neurosurgery at NYU Grossman School of Medicine and chief of neurosurgery at NYC Health + Hospitals/Bellevue, said in a press release.
“Future studies should track these injuries across multiple cities and measure whether protected bike lanes, helmet programs, and speed enforcement actually reduce the number of brain and spine surgeries we perform,” Huang added,
Jade A. Cobern, MD, MPH, is a practicing physician, board-certified in pediatrics and general preventive medicine, and is a fellow of the ABC News Medical Unit.
Robert F. Kennedy Jr., US secretary of Health and Human Services (HHS), during a healthcare affordability event in the South Court Auditorium of the Eisenhower Executive Office Building at the White House in Washington, DC, US, on Monday, May 18, 2026. (Photographer: Jim Lo Scalzo/EPA/Bloomberg via Getty Images)
(WASHINGTON) — Health and Human Services Secretary Robert F. Kennedy Jr. told ABC News on Monday that his agency is working to address the recent hantavirus and Ebola outbreaks, marking the first time he’s commented publicly on the Ebola outbreak since the Centers for Disease Control and Prevention (CDC) confirmed than an American had been infected with the virus in the Democratic Republic of the Congo (DRC).
“Yeah, we’re working on it,” Kennedy told ABC News when asked if he was worried about the outbreaks. The secretary’s comments come after the CDC said a “small number of Americans” are directly affected by the current Ebola outbreak in the DRC.
Kennedy did not respond when asked what his message might be to Americans who are concerned about the diseases potentially spreading in America. He told reporters in the Oval Office last week that the U.S. had the hantavirus outbreak “under control.”
“We have this under control and we’re not worried about it,” he said at the White House’s maternal healthcare event on May 11th. Kennedy also noted that the CDC has been working on the outbreak since day one.
The CDC said there have been no confirmed hantavirus cases in the U.S. linked to the MV Hondius cruise ship and 18 passengers remain under observation at the University of Nebraska.
Meanwhile, Kennedy’s brief comments about the outbreaks came following a roundtable event announcing nearly $1 billion in new funding to states to address PFAS in drinking water at the Environmental Protection Agency (EPA) on Monday.
The secretary has been on a midterm blitz recently, touting the administration’s Make America Healthy Again (MAHA) movement during stops including Ohio and California.
At a subsequent event featuring Kennedy and other health leaders at the White House, Deputy Assistant to the President for Domestic Policy Heidi Overton stressed that “there are no cases of Ebola in America.”
Deputy Assistant to the President for Domestic Policy Heidi Overton stressed during the event that “there are no cases of Ebola in America.”
“We want to keep it that way and we are doing everything we can to support Americans in the region,” Overton added.
